$CGNX

Long Darren Marc sold $1.3M of CGNX

Long Darren Marc (Vice President) sold 20,252 shares of COGNEX CORP (CGNX) at an average of $66.34 ($66.32–$66.52, $1.34M total) across 4 trades on 2026-05-27.

Original reporting
SEC EDGAR · Long Darren Marc
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CGNX
Neutral
medium confidence
Mentioned
$CGNX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CGNXNeutralLow
01

Why it matters

This is a disclosed open-market sale by a VP, which can marginally influence sentiment but does not introduce new guidance, contracts, litigation, or operational changes.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the disclosure alone is unlikely to be a standalone driver.

03

What to watch

The filing shows remaining holdings (3,990 shares) and multiple small trades, which can reflect routine execution rather than a directional view.

Relevance 6/10Novelty 3/10Timing: Filed 2026-05-28, covering sales executed 2026-05-27.

Background

The article is an SEC Form 4 insider transaction disclosure for Cognex (CGNX).

Company-level read

Ticker impact

$CGNXNeutralMedium confidence
Context

Cognex VP Darren Marc sold about $1.34M of CGNX shares in an open-market transaction reported on SEC Form 4.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless paired with other news.

Evidence & confidence

The filing is a Form 4 insider sale (not a buy), but it provides no new company-specific operational or financial information, and the transaction is already dated (2026-05-27).

Market effects

Minimal; insider sale does not change broader industrial automation or machine vision fundamentals.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for liquidity or diversification; absence of a stated 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • Cognex

    Company whose insider transaction is disclosed on SEC Form 4.

  • Long Darren Marc

    Vice President who sold CGNX shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CGNXMed

Cognex, Insight Enterprises, and SAIC Stocks Trade Down, What You Need To Know

Cognex (CGNX), Insight Enterprises (NSIT), and SAIC (SAIC) fell 4%, 3.8%, and 2.8% respectively, as September inflation rose to 3.7%, surpassing expectations and driving bond yields higher. Elevated inflation and interest rates may compress valuations, particularly in growth sectors like technology. Cognex's volatility continues, with shares down 20.5% from their 52-week high. Truist lowered its price target for Cognex to $74, maintaining a Hold rating.

$CGNXMed

CGNX Maintained by Barclays -- Price Target Raised to $85.00

Barclays maintained an Overweight rating on Cognex (CGNX) and raised its price target to $85.00 from $80.00. The company's GF Value™ suggests it is 15.6% overvalued, while its GF Score™ is 86/100. Cognex is a leading manufacturer of machine vision systems, with a market cap of $10.38 billion. Insider activity shows mixed sentiment, with some gurus adding positions while others trimmed.

$CGNXMed

Why Cognex (CGNX) Stock Is Falling Today

Cognex (CGNX) shares fell 7.5% due to rising Treasury yields, oil prices, and a Truist price target cut to $74. The company's stock is volatile, up 67.5% YTD but down 14.6% from its 52-week high. Truist expects constructive company commentary despite near-term challenges.

$CGNXHighAI 9/10

Shifting to physical AI, Cognex to acquire RealSense in $500 million deal

Cognex Corporation is acquiring RealSense, an Israeli AI vision technology developer, for $500 million in cash and a $50 million stock option. The deal, expected to close in Q4 2026, will expand Cognex into robotic perception and Physical AI. RealSense, with 180 employees, is a key supplier for autonomous robots and expects $80-90 million in 2026 revenue, up over 50% year-over-year.